Original article| Volume 51, ISSUE 4, P280-287, February 15, 2002

Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes


      Background: Vagus nerve stimulation has shown promising results in an open, acute phase pilot study of adults in a treatment-resistant major depressive episode. This open, naturalistic follow-up study was conducted to determine whether the initial promising effects were sustained, and whether changes in function would be observed.
      Methods: Thirty adult outpatients in a treatment-resistant, nonpsychotic major depressive episode received an additional 9 months of vagus nerve stimulation treatment following exit from the 3-month acute study. Changes in psychotropic medications and vagus nerve stimulation stimulus parameters were allowed during this longer-term follow-up study. A priori definitions were used to define response (≥ 50% reduction in baseline Hamilton Rating Scale for Depression total score) and remission (Hamilton Rating Scale for Depression ≤ 10).
      Results: The response rate was sustained [40% (12/30) to 46% (13/28); p = .317] and the remission rate significantly increased [17% (5/30) to 29% (8/28); p = .045] with an additional 9 months of long-term vagus nerve stimulation treatment after exit from the acute study (1 year total vagus nerve stimulation treatment). Significant improvements in function between acute study exit and the 1-year follow-up assessment as measured by the Medical Outcomes Study Short Form-36 were observed.
      Conclusions: Longer-term vagus nerve stimulation treatment was associated with sustained symptomatic benefit and sustained or enhanced functional status in this naturalistic follow-up study.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • American Psychiatric Association
        Diagnostic and Statistical Manual of Mental Disorders. 4th ed. American Psychiatric Association, Washington, DC1994
        • American Psychiatric Association Committee on Electroconvulsive Therapy
        The Practice of Electroconvulsive Therapy. 2nd ed. American Psychiatric Association, Washington, DC2001
        • Ben-Menachem E
        • Manon-Espaillat R
        • Ristanovic R
        • Wilder B.T
        • Stefan H
        • Mirza W
        • et al.
        Vagus nerve stimulation for treatment of partial seizures.
        Epilepsia. 1994; 35: 616-626
        • Byrne S.E
        • Rothschild A.J
        Loss of antidepressant efficacy during maintenance therapy.
        J Clin Psychiatry. 1998; 59: 279-288
        • Coppen A
        • Ghose K
        • Montgomery S
        • Rama
        • Rao V.A
        • Bailey J
        • Jorgensen A
        Continuation therapy with amitriptyline in depression.
        Br J Psychiatry. 1978; 133: 28-33
        • DeGiorgio C.M
        • Schachter S.C
        • Handforth A
        • Salinsky M
        • Thompson J
        • Uthman B
        • et al.
        Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures.
        Epilepsia. 2000; 41: 1195-1200
        • Department of Health and Human Services, Center for Drug Evaluation and Research, Office of Epidemiology Biostatistics
        Coding Symbols for Thesaurus of Adverse Reaction Terms. 5th ed. US Department of Commerce, National Technical Information Service, Rockville, MD1995
        • Entsuah A.R
        • Rudolph R.L
        • Hackett D
        • Miska S
        Efficacy of venlafaxine and placebo during long-term treatment of depression.
        Int Clin Psychopharmacol. 1996; 11: 137-145
        • Frank E
        • Kupfer D.J
        • Perel J.M
        • Cornes C
        • Jarrett D.B
        • Mallinger A.G
        • et al.
        Three-year outcomes for maintenance therapies in recurrent depression.
        Arch Gen Psych. 1990; 47: 1093-1099
        • Frank E
        • Kupfer D.J
        • Perel J.M
        • Cornes C
        • Mallinger A.G
        • Thase M.E
        • et al.
        Comparison of full-dose versus half-dose pharmacotherapy in the maintenance treatment of recurrent depression.
        J Affect Disord. 1993; 27: 139-145
        • Gagne G.G
        • Furman M.T
        • Carpenter L.L
        • Price L.H
        Efficacy of continuation ECT and antidepressant drugs compared with long-term antidepressants alone in depressed patients.
        Am J Psychiatry. 2000; 157: 1960-1965
        • Guy W
        NCDEU Assessment Manual for Psychopharmacology. US Public Health Service, Rockville, MD1976 (Department of Health, Education and Welfare Publication No. ADM 76–338)
        • Hamilton M
        Development of a rating scale for depression.
        Br J Soc Clin Psychol. 1967; 6: 278-296
        • Handforth A
        • DeGiorgio C.M
        • Schachter S.C
        • Uthman B.M
        • Naritoku D.K
        • Tecoma E.S
        • et al.
        Vagus nerve stimulation therapy for partial-onset seizures.
        Neurology. 1998; 51: 48-55
        • Montgomery S.A
        • Asberg M
        A new depression scale designed to be sensitive to change.
        Br J Psychiatry. 1979; 134: 382-389
        • Montgomery S.A
        • Dufour H
        • Brion S
        • Gailledreau J
        • Laqueille X
        • Ferrey G
        • et al.
        The prophylactic efficacy of fluoxetine in unipolar depression.
        Br J Psychiatry. 1988; 153: 69-76
        • Montgomery S.A
        • Dunbar G
        Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression.
        Int Clin Psychopharmacol. 1993; 8: 189-195
        • Morris G.L
        • Mueller W.M
        Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. Vagus Nerve Stimulation Study Group (EO1-E05).
        Neurology. 1999; 53: 1731-1735
        • Prien R.F
        • Kupfer D.J
        • Mansky P.A
        • Small J.G
        • Tuason V.B
        • Voss C.B
        • et al.
        Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders.
        Arch Gen Psych. 1984; 41: 1096-1104
        • Quitkin F.M
        Placebos, drug effects, and study design.
        Am J Psychiatry. 1999; 156: 829-836
        • Quitkin F.M
        • Stewart J.W
        • McGrath P.J
        • Nunes E
        • Ocepek-Welikson K
        • Tricamo E
        • et al.
        Loss of drug effects during continuation therapy.
        Am J Psychiatry. 1993; 150: 562-565
        • Rush A.J
        • George M.S
        • Sackeim H.A
        • Marangell L.B
        • Husain M.M
        • Giller C
        • et al.
        Vagus nerve stimulation (VNS) for treatment-resistant depressions.
        Biol Psychiatry. 2000; 47: 276-286
        • Sackeim H.A
        • Haskett R.F
        • Mulsant B.H
        • Thase M.E
        • Mann J.J
        • Pettinati H.M
        • et al.
        Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy.
        JAMA. 2001; 285: 1299-1307
        • Sackeim H.A
        • Keilp J.G
        • Rush A.J
        • George M.S
        • Marangell L.B
        • Dormer J.S
        • et al.
        The effects of vagus nerve stimulation on cognitive performance in patients with treatment-resistant depression.
        Neuropsychiatry, Neuropsychol Behav Neurol. 2001; 14: 53-62
        • Sackeim H.A
        • Prudic J
        • Devanand D.P
        • Decina P
        • Kerr B
        • Malitz S
        The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression.
        J Clin Psychopharmacol. 1990; 10: 96-104
        • Sackeim H.A
        • Prudic J
        • Devanand D.P
        • Kiersky J.E
        • Fitzsimmons L
        • Bobba J.M
        • et al.
        Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy.
        N Engl J Med. 1993; 328: 839-846
        • Sackeim H.A
        • Prudic J
        • Devanand D.P
        • Nobler M.S
        • Lisanby S.H
        • Peyser S
        • et al.
        A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities.
        Arch Gen Psychiatry. 2000; 57: 425-434
        • Sackeim H.A
        • Rush A.J
        • George M.S
        • Marangell L.B
        • Husain M.M
        • Nahas Z
        • et al.
        Vagus nerve stimulation (VNS) for treatment-resistant depression.
        Neuropsychopharmacology. 2001; 25: 713-728
        • Salinsky M.C
        • Uthman B.M
        • Ristanovic R.K
        • Wernicke J.F
        • Tarver W.B
        • Vagus Nerve Stimulation Study Group
        Vagus nerve stimulation for the treatment of medically intractable seizures.
        Arch Neurol. 1996; 53: 1176-1180
        • Schmidt M.E
        • Fava M
        • Robinson J.M
        • Judge R
        The efficacy and safety of a new enteric-coated formulation of fluoxetine given once weekly during the continuation treatment of major depressive disorder.
        J Clin Psychiatry. 2000; 61: 851-857
        • Vagus Nerve Stimulation Study Group
        A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures.
        Neurology. 1995; 45: 224-230
        • Ware Jr, J.E
        • Sherbourne C.D
        The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.
        Med Care. 1992; 30: 473-483
        • Williams J.B.W
        A structured interview guide for the Hamilton Depression Rating Scale.
        Arch Gen Psychiatry. 1988; 45: 742-747
        • Young R.C
        • Biggs J.T
        • Ziegler V.E
        • Meyer D.A
        A rating scale for mania.
        Br J Psychiatry. 1978; 133: 429-435